tetano
Editor, Senior Moderator
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) welcomes the outcome of the WHO Open-Ended Working Group of Member States on Pandemic Influenza Preparedness (OEWG/PIP). The Working Group has reached a decision that will result in an effective global system to prepare for potential future influenza pandemics, recognizing a shared responsibility to help secure the world against future pandemic influenza outbreaks. The IFPMA supports the reported principles of the decision, and awaits with interest the final report of the OEWG/PIP in order to comment on the detail of the framework. It will be crucial to have a system that allows for rapid access to pandemic viruses and for benefits to be allocated to those countries most in need.
The decision reached by Member States on the framework suggest that the key challenges have been addressed by the OEWG/PIP; such as increasing the capacity of vaccine production and enabling access in developing countries. The financial parameters for IFPMA support to the WHO Global Influenza Surveillance Network (GISN) appear to have been accepted, as have the levels for IFPMA members' allocations for vaccines and antivirals to be made available for developing country use at the next pandemic.
...
http://www.medicalnewstoday.com/articles/222682.php
The decision reached by Member States on the framework suggest that the key challenges have been addressed by the OEWG/PIP; such as increasing the capacity of vaccine production and enabling access in developing countries. The financial parameters for IFPMA support to the WHO Global Influenza Surveillance Network (GISN) appear to have been accepted, as have the levels for IFPMA members' allocations for vaccines and antivirals to be made available for developing country use at the next pandemic.
...
http://www.medicalnewstoday.com/articles/222682.php